Lead sponsor
Avraham Pharmaceuticals Ltd
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
0
Ongoing
410
Total enrollment
29
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
2
Trials by status
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive ImpairmentAlzheimer's diseasePh 2Completed210
Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Diseasemild-to-moderate ADPh 2Completed200